SpreadLove In Organizations - Healthcare Leadership

Leading through pandemics, crises, innovation breakthroughs, and transformations is Dr. Doug Bruce's specialty. From HIV pandemic management in most hit countries to leading large transformations in the US healthcare system, Doug will share his key learning from overcoming silos to reaching the "truth" in moments of crisis and change. His leadership lessons are insightful for all of us whether in public health, private sector, or NGO: be creative, be a listener, and be humble. Doug spreads love by treating people with dignity, ensuring they know and perceive their value, and this spreads to patients... "We build trust through transparency, humility, and honesty." MEET OUR GUEST Dr. Doug Bruce associate Chief of Clinical Affairs at Boston University School of Medicine. Dr. Robert Doug Bruce is Associate Chief of Clinical Affairs at Boston University School of Medicine and Director of Primary Care at Boston Medical Center (BMC). Prior to those roles, Doug transformed healthcare in the New Haven community focusing on the largest health center in new haven on quality and value-based care which resulted in significant savings for CT Medicaid and the community. Doug was also Chief of Medicine at Cornell Scott-Hill Health Center and Associate Clinical Professor of Medicine at Yale University. Doug is a global expert in substance use disorders in people with HIV and hepatitis C. He has published widely on the topic of substance use disorders and HIV. He has provided technical assistance to CDC, NIH, and the United Nations. In September 2020, Doug moved to Boston to join BU and BMC to continue practice transformation, innovation, and quality improvement within a safety net organization’s large academic medical practice.

There are too many issues in the world that we need to solve! This is what drives Rosemarie Day and connects her to her purpose. Her strongest belief is that healthcare is a human right. Through her sense of purpose, collaboration, a healthy dose of patience balanced with impatience and a sense of urgency, Rosemarie led large healthcare reforms that made life better for millions of people. Listen to her story, her journey, her insights, and why she believes that women can lead the fight for universal healthcare and be the voice of change. "Take the longer view and stick with it." MEET OUR GUEST Rosemarie Day, Founder & CEO of Day Health Strategies; Author & Speaker. Rosemarie Day served as the founding Deputy Director & Chief Operating Officer of the Health Connector in Massachusetts. At the Health Connector in 2006, she helped lead the launch of health reform in Massachusetts, which became the model for the Affordable Care Act. Prior to this role, she was the Chief Operating Officer of the Massachusetts Medicaid program, among other state leadership positions. She has been working on health reform ever since, and is passionate about universal healthcare and women's health issues. She is the founder and CEO of Day Health Strategies, a successful mission-driven, woman-owned consulting firm that celebrated its 12th anniversary in July.  As a healthcare reform expert and CEO, Rosemarie Day, who is also a breast cancer survivor, has written a book to galvanize women to take action to make health care a right in the US. Its title is “Marching Toward Coverage: How Women Can Lead the Fight for Universal Healthcare” (Beacon Press, 2020). With 28 million Americans uninsured, and millions more who can’t afford their coverage, Rosemarie asks the fundamental question: Can we, as a nation, do better? Rosemarie believes we can and will—once women begin to engage collectively around this topic. Rosemarie brings a feminist lens to the universal health care debate and seeks to empower more women to engage in that debate. She simplifies complex policy ideas about making change in the health care coverage system into an approachable and engaging framework. She combines a personal perspective on health policy with a professional perspective – she’s at once a health policy expert, strategist, and implementer, as well as a mother, daughter and friend who has faced some challenging health issues. She offers no easy panacea, but instead delivers a pragmatic path forward, one that recognizes health care as a fundamental human right, factors in the role of social determinants, and ensures coverage for all. More about Rosemarie’s work here: https://rosemarieday.com/ Links to her book: Barnes and Noble, Indiebound, Amazon, Beacon, Penguin Random House, and Porter Square Books.

When we think of inspiring leaders, we remember those we learned from by watching how they did what they do. It is those we want to follow and be like. It is those who made us feel valued and heard, those who made us grow after each interaction even when it is an unpleasant conversation. Because people remember how they felt when you left the room, lead from a place of genuine care and love. Hear more from Susan Silbermann, her journey, and more of those incredible insights and learning she's sharing with us. "Ask the questions because you want to move the ball forward." MEET OUR GUEST Susan Silbermann, an accomplished, global senior business executive, with broad experience in healthcare across multiple geographies. Curious by nature, Susan is an authentic and communicative leader who is adept at leading remote, diverse teams and who excels at working cross-functionally. This reputation extends to interactions in the policy, government affairs, and public health arenas. She is a Board Director at HilleVax Inc (Comp Chair) and LianBio (NomGov Chair) and was recently appointed to the Board of Directors of IAVI, the International AIDS Vaccine Initiative. She is also a member of the board of Meet the Writers, a non-profit organization bringing together authors and students in low-income NYC public schools. Previously Susan served on numerous not-for-profit and NGO boards, including Gavi, the Vaccines Alliance (member of Governance Committee); Catalyst Inc; and the Council of the Americas. In March 2021, she stepped down as Vice-Chair of the President’s Council for Doing Business in Africa. Before retiring from Pfizer last year, Susan led a then $8B revenue, 10,000 colleagues Emerging Markets division, and Pfizer’s internal Global COVID-19 Task Force, ensuring the safety and well-being of 75,000 employees, facilities, and medicine and vaccine supply chain. In her prior role, Susan was the Global President of Pfizer Vaccines, leading operations, commercial, and business development. Susan is looking forward to whatever lies ahead — and looking backward doesn’t really lead you anywhere new, does it?

"What makes you tick?" Alon Shklarek took this question to a deep reflection that led him to be free. Free to create impact through businesses, live his purpose to improve the world, and fix meaningful problems. His deep belief is that every company should have a social impact focus, and deeply think about how with their capabilities they can make the world a better place. Hear his thoughts on leadership being a team sport, his views on entrepreneurship, him not being George Clooney, and his words of wisdom on impact. "When I see a problem I care about, I start a business." MEET OUR GUEST Alon Shklarek, serial impact entrepreneur, investor, and enabler. Alon has founded, co-founded, and invested in over 25 businesses across 16 countries to date. Whether it is his ventures in the digital health space that are improving health outcomes for thousands of patients every day or his sustainability-focused ventures such as his leading plastics recycling company that gives over 100.000 tons of plastic waste a second life every year, all his companies are focused around leading with purpose and impact. As an active Impact Investor Alon directly supports and mentors selected social entrepreneurs and is an ASN member of Ashoka, the world’s leading social entrepreneurship organization. Besides, Alon teaches Leadership and Entrepreneurship as Guest Lecturer at MIT. More from Alon: Blog: https://www.alonshklarek.com/blog/category/blogpost/ Twitter: https://twitter.com/alonshklarek

It starts with the right people to solve the 75 steps! Jonathan Fleming is clear on what it takes to build successful biotech companies. He has built, cofounded, and funded several companies serving and changing the lives of millions of patients worldwide. Great leaders are humble and mindful enough to understand the blessing they were given for them to give back. They lead with care and love, especially in healthcare. Leadership is also about knowing when to go. In this provocative episode, you will hear incredible insights and straightforward words of wisdom. A great summary for us leading healthcare organizations: we should never forget our moral, ethical, and legal responsibility for patients, employees, and shareholders. "Leading with love and care is something you should do to the core of your being in healthcare." MEET OUR GUEST Jonathan Fleming Executive Chairman of QurAlis and Enclear Therapies. Former President and CEO of Q-State Biosciences, and former Managing Partner of Oxford Bioscience Partners, an international venture capital firm specialized in life science investments. Jonathan has been founding, financing, and operating breakthrough life science companies for over 30 years in the USA, Europe, Asia, and the Middle East. During his career, he has raised more than $1 billion for early-stage investment funds that made more than 200 investments resulting in over 20 IPOs and 40 M&A events. Jonathan has been the CEO of a neuroscience company, been the chairman of the board of numerous organizations, and been a director of many public and private companies. He has participated in the creation of numerous startups and has worked with seven different Nobel laureates to create and build companies based upon their work. Jonathan has been a senior lecturer at the Sloan School since 2002 where I met him in an incredible class on strategic decisions in Life Science. 

Diversity, Equity, Inclusion, and don't forget Belonging. Belonging is one of the most crucial aspects we talk less about but greatly impacts us. We also talked about Health Equity, what it means, and what we can do as healthcare leaders - it starts by raising the problem for us to start solving it! Hear why quality is about love and other incredible insights in this conversation with a Top Voice in healthcare, Dr. Umbereen Nehal. "You have to raise a problem for it to be problem-solved." MEET OUR GUEST Umbereen S. Nehal, MD, MPH is a Dean’s Fellow and Sloan Fellow at the MIT Sloan School of Management. Her work is at the intersection of technology, policy, and healthcare delivery to diverse populations. Umbereen is a recognized thought leader on human-centered health information technology (HIT) design, ethical artificial intelligence (AI), payment reform, quality, and reducing disparities. Educated at Aga Khan University Medical School and the Harvard School of Public Health, Dr. Nehal trained at Texas Children’s Hospital and Baylor College of Medicine followed by the Harvard Pediatric Health Services Research Fellowship at Boston Children’s Hospital. Four times Dr. Nehal has been named “LinkedIn Top Voice” for “Healthcare” and as a “Top Female Voice” on International Women’s Day. As Chief Medical Officer and Vice President of Medical Affairs of Community Healthcare Network, Dr. Nehal led a 14-site multi-specialty certified Patient-Centered Medical Home (PCMH) serving 85,000 New Yorkers including behavioral health integration and telehealth. She had oversight of over 700 staff and a $100 million operating budget. Dr. Nehal served as Associate Medical Director of MassHealth -- a Medicaid program serving 1.6 million members and accounting for 40% of the state budget -- providing leadership on program development and evaluation, cost effectiveness evaluation, population health initiatives, and state-wide information “HIway” for intraoperability. Dr. Nehal served as clinical lead for the 5-year restructuring to create new Accountable Care Organization (ACO) models, co-leading a successful bid for $1.8b in new investment from Centers for Medicare and Medicaid Services (CMS). Dr. Nehal has expertise in leading multi-disciplinary teams for change management. She designed novel HIT for Medicare Advantage plans to track and rank new forms of data used for payment by CMS and contributed to a Series C fund raise for a client that offers an integrated cloud-based medial data and extraction platform enhanced by AI and natural language processing (NLP). As an MIT Sloan Fellow Dr. Nehal led an AI-focused hackathon, drawing hundreds of innovators from around the world, for human-centered design solution in the age of COVID-19 and was an invited senior author on a chapter on business models, payment metrics, and business ethics for medical AI. Dr. Nehal served as co-chair of the Patient-Centered Outcomes Research Institute (PCORI) Healthcare Delivery and Disparities Research advisory panel, she informed national funding priorities for a portfolio of over $300 million clinical effectiveness evaluations. She co-authored national curriculum on the Patient-Centered Medical Home, now disseminated to over 8,000 residents. She is published on use of the Electronic Health Record (EHR) to promote transition planning for children with disabilities. She provided expert review to the Connecticut Department of Public Health’s medical home curriculum. Elected by her peers, she served as district representative and on the board for the Massachusetts Chapter of the American Academy of Pediatrics. A frequent invited stakeholder to the White House, CMS, HHS, and NIH, she was asked to moderate a panel for U.S. Surgeon General, Dr. Regina Benjamin. Dr. Nehal served as the Principal Investigator of a community health grant to partner with community-based organizations and faith groups in low-resourced communities to promote improved heart health aligned with the Culture of Health. Dr. Nehal’s national leadership on community engagement won recognition from President Obama.

In this episode, I had a great conversation with a leader in Mindset: Aden Eyob. Aden is a clinical neuroscientist and author of the Book on Mind Training: The Secret for Positive Living. She is the founder and CEO of Mind Medication, a fusion of neuroscience-psychology and spirituality-based mindset consulting and speaker service that helps uncover people’s “why”, unlock potential, and free limiting beliefs to achieve the impossible. Aden’s mission is a world free from limiting beliefs. Her formula is straightforward: Change your thought for it to be positive, it brings positive emotions and leads to the correct behavior. Hear about her great CALM framework: Clarity of the why, Accountability of goals, Love and self-care, and Motivators. "Thought + Emotion = Behavior" MEET OUR GUEST Aden Eyob, Founder & CEO at Mind Medication, Author, Speaker, and Clinical Neuroscientist. Aden has over ten years of business experience working with Fortune 500 companies, including Gilead Sciences, Kite Pharma, Medpace, Kantar Health, Ogilvy Healthworld, and academic institutions such as UCLA and Charles R. Drew University. Currently, Aden is the founder and CEO of Mind Medication, a fusion of neuroscience-psychology and spirituality-based mindset consulting, coaching, and speaker service that helps organizations uncover their why, unlock potential; and free limiting beliefs to achieve the impossible. Before beginning her business, Aden spent most of her career in Biotechnology, most notable, three years at Gilead Sciences / Kite Pharma. She worked as a Clinical Trial Management professional within the oncology therapy unit. She also led Gilead’s Leadership Organization of Black Employees (GLOBE) Community Outreach Pillar, which engages in philanthropic endeavors and investments that provide opportunities to give back to the UK communities in which Gilead operates. Aden’s innovative thinking and mindfulness approach towards her career, health, and personal commitments were recognized by her peers and awarded the Women at Gilead Life Balance Award for 2018. Moreover, Aden is the recipient of Brainz CREA Global Awards 2021 in recognition of her innovative ideas, adaptability in business, and contribution to mental health projects.

Zen Chu built and invested in several successful medical and healthcare companies, his key to success: People first. When reflecting on the investor side, this doesn't change either, it starts with people. For Zen, the best leaders and investors are those focused on impact, and when love is in their life, it allows them to be laser-focused on the impact they bring. In this episode, hear Zen's incredible personal story and journey, his insightful advice, and lessons learned from leading turnarounds to building extremely successful ventures! "Love in your life allows you to focus purely on impact." MEET OUR GUEST Zen Chu, Health Tech Serial Entrepreneur, and Investor. Faculty Director for the Healthcare Ventures graduate courses and Hacking Medicine student teams at MIT, Harvard Medical School and UCLA. As founder of four medical companies and Hacking Medicine Venture Capital fund, Zen has 25 years of experience building early-stage medical technology and healthcare service companies, usually serving among the first investors in companies like PillPack.com, Abridge.com, FeelMore Labs, Nurx.com, Aptible, Luminopia, Molecule.to, MycoMedica, DirectDerm and a few others still in stealth mode. Zen cofounded and served as CEO for 3D-Matrix Medical Inc. a venture-backed MIT regenerative medicine company with a successful IPO in 2011. 3D-Matrix has wound-healing and drug-delivery products on the market outside of the US and multiple human clinical trials in process. I met Zen through the MIT Healthcare Ventures, a course that teaches entrepreneurship, business models, and venture creation around technology that can transform healthcare. Zen actively consults companies in pharma, health tech, and healthcare systems struggling to adapt to global digital healthcare transformation and emerging markets.

You rarely chat with a leader with such extensive successful experience, from building companies to being on boards of large institutions, whose purpose is to make people happy. Through his humility and focus on mutual respect, transparency, and honesty, Jim Dougherty believes that one of the most important keys to success is the culture you create in a company. For him, culture should be created strategically in every company including startups, and not only be words on a wall or a slide. You'll hear incredible advice on how to lead turnarounds while engaging teams to thrive and be at their best. In the end, people will remember how they felt with you, and this is the legacy that will remain... "People want to work with you because they want to learn how to behave like you." MEET OUR GUEST Jim Dougherty Executive Chairman and Co-Founder at Madaket Health. Jim is an entrepreneur, senior executive, and also Senior Lecturer in Technological Innovation, Entrepreneurship, and Strategic Management at MIT. He has extensive experience working directly with investors to execute highly successful turnarounds of troubled companies. He has stabilized and recapitalized such companies as Gartner, IntraLinks, Prodigy, and Small Business ISP. At Lotus Development Corporation, Jim was the founder of eApps (Internet Division), and he created the NOTES: NEWSSTAND business publishing service which was later sold successfully. He is also an Adjunct Senior Fellow for Business and Foreign Policy at the Council on Foreign Relations. He sits on the board of different institutions too. Jim is on the Board of Trustees for Beth Israel Deaconess Medical Center, where he Chairs the Research Oversight Committee, Bright Spirit Children's Foundation, and the Foreign Policy Association in New York City. Jim holds a BA in government from Framingham State University, an MA in international economics from Columbia University, and a Graduate Certificate of Special Studies in finance and administration from Harvard University. Here are the great articles from Jim Dougherty we mentioned in the episode published in Harvard Business Review - HBR.

AI is simply the future, more explicitly Dimitris Bertsimas likes to talk about analytics which is for him the science of using data to build models that lead to decisions that impact the world positively. Personalized medicine is the aspiring future that we will get to soon. As leaders, we will have to drive those changes. This needs courage and openness to what data tells us. Hear from a leader who changed medical practices through data, models and decisions and impacted positively thousands of lives. "The beauty of computers is they don't get tired", but they can't replace humans, hear more about it in this episode. "Love is the most significant aspect of human happiness" MEET OUR GUEST Dimitris Bartsimas Associate Dean of Business Analytics, Boeing Professor of Operations Research, and faculty director of the Master of Business Analytics at MIT. Dimitris is Global Operations Professor of Management, a Professor of Operations Research, and the Associate Dean for the Master of Business Analytics at MIT. A faculty member since 1988, his research interests include optimization, stochastic systems, machine learning, and their application. In recent years, he has worked in robust optimization, statistics, healthcare, transportation, and finance. Dimitris is also a serial entrepreneur and was a co-founder of Dynamic Ideas, sold to American Express. He is also the founder of Dynamic Ideas Press, a publisher of scientific books, the cofounder of Benefits Science, a company that designs health care plans for companies, Dynamic Ideas Financial, a company that provides financial advice to customers, of Alpha Dynamics, an asset management company, P2 Analytics, an analytics consulting company, and of MyA health, a personalized health care advice company.  Dimitris has coauthored more than 200 scientific papers and several books. He is the former department editor of Optimization for Management Science and of Operations Research in Financial Engineering. A member of the National Academy of Engineering and an INFORMS fellow, he has received numerous research awards, including the Harold Larnder Prize (2016), the Philip Morse Lectureship prize (2013), the William Pierskalla best paper award in health care (2013), best paper award in Trapsoration (2013), the Farkas Prize (2008), the Erlang Prize (1996), the SIAM Prize in Optimization (1996), the Bodossaki Prize (1998), and the Presidential Young Investigator Award (1991–1996). He has also received recognition for his educational contributions: The Jamieson prize (2013) and the Samuel M. Seegal prize (1999).  Dimitris holds a BS in electrical engineering and computer science from the National Technical University of Athens, Greece, as well as an MS in operations research and a PhD in applied mathematics and operations research from MIT.